Quick Summary
Womab Injection
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹59995
MRP: ₹74992.5
(You Save ₹14997.5)
1 VIAL(s)
Womab Injection
Salt Composition
PERTUZUMABMarketer
DR REDDY'S LABORATORIES LTD
Prepaid Only. Non-Returnable.
20% OFF
₹59995
MRP: ₹74,992.50
Inclusive of all taxes
20% Off
Salt Composition
PERTUZUMABMarketer
DR REDDY'S LABORATORIES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Intazumab 420mg Injection
INTAS PHARMACEU...
₹ 21250.00/injection
64% cheaper
Perzea 420mg Injection
HETERO HEALTHCA...
₹ 24592.00/injection
59% cheaper
Her2 P 420mg Injection
MANKIND PHARMAC...
₹ 57597.00/injection
3% cheaper
Sigrima 420mg Injection
ZYDUS CADILA
₹ 59997.00/injection
1% costlier


Introduction
Womab Injection is an anticancer medication containing the active constituent Pertuzumab. It is used to treat a type of breast cancer (HER2-positive breast cancer) in combination with other chemotherapy medications. Cancer is a condition in which cells multiply uncontrolled and abnormally.
Womab Injection is not recommended for adolescents and children under 18 years of age. Before taking this medicine, it is vital to inform your doctor if you have or have ever had heart problems or chemotherapy. Use effective birth control during the treatment and for at least six months after the last dose.
Inform your doctor if you have kidney disease before starting with this Pertuzumab injection. Patients with kidney disease should cautiously use this medicine. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medicine. Do not stop taking this medication without talking to your physician first.
Uses
HER2-positive breast cancer
How Womab Injection works
Womab Injection binds to the human epidermal growth factor receptor 2 (HER2) on cancer cells, potentially destroying or inhibiting cancer cell growth.
Interaction of Womab Injection with other drugs
Inform your healthcare provider about all your medicines, including prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Womab Injection and reduce effectiveness by causing undesirable side effects.
Storage conditions
- Keep Womab Injection out of sight and reach of children.
-
Store in refrigerator at 2°C to 8°C. Do not freeze.
How to use Womab Injection
Womab Injection is available as an injection and administered intravenously once every three weeks. Follow your physician's instructions. Your doctor will determine the frequency and dose of administration because it varies for each person depending on the disease condition. Don’t self-administer.
Safety Advices
Pregnancy
Inform your doctor in case you are pregnant, think you might be pregnant or are planning to get pregnant, as Womab Injection may be unsafe during pregnancy.
Breast Feeding
It may be unsafe to take Womab Injection while breastfeeding. Consult your doctor if you are breastfeeding before taking this medication.
Lungs
It is unknown whether Womab Injection is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
Womab Injection is used with caution in patients with liver impairment. Inform your physician about the pre-existing medical conditions. Your physician will monitor your liver functions and adjust the dose accordingly.
Alcohol
It is not known whether it is safe to consume alcohol with Womab Injection. Please consult your doctor.
Driving
Womab Injection may cause dizziness, infusion reaction, and other minor effects. So, avoid driving if you are unwell.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
-
Severe or persistent diarrhea
-
Low white blood cell count
-
Infusion reactions (fever, chills, hot flushes, nausea, headache, joint, and muscle pain)
-
Severe allergic reactions (swelling of throat and face, difficulty in breathing)
-
Heart problems (cough, swelling in arms or legs, shortness of breath)
-
Tumour lysis syndrome (confusion, tiredness, irregular heartbeat, seizures, tingling sensation)
Common
-
Hair loss
-
Rash
-
Sore mouth
-
Constipation
-
Poor appetite
-
Changes in taste
-
Sleeping troubles
-
Nose bleeds
-
Heartburn
-
Nail problems
-
Producing more tears
-
Feeling dizzy
-
Dry and itchy skin
-
Ear, nose, or throat infection.
Expert tips
-
Womab Injection can cause heart-related problems such as heart failure, irregular heartbeats, and uncontrolled high blood pressure.
-
Inform your doctor about your medical history before starting treatment.
-
If you experience any of the above symptoms, consult your doctor immediately.
-
Use effective contraception during treatment.
-
Continue using contraception for six months after stopping the treatment.
FAQs
Q1.
Does Womab Injection cause any heart problems?
Womab Injection can damage the heart muscle and increase the risk of heart problems. Notify your doctor if you have any history of heart problems.
Q2.
Should I use contraception even after the treatment with Womab Injection?
Yes, Using contraception during and after treatment with Womab Injection for at least six months is necessary.
Q3.
Can Womab Injection be self-administered?
No, Womab Injection should not be self-administered and must be given only under the supervision of a healthcare professional.
Q4.
What should I tell my doctor before taking the Womab Injection?
Inform your doctor about the history of your high blood pressure, irregular heartbeat, heart failure, and other heart-related problems.
Q5.
Is it okay to take new medication while taking Womab Injection?
Inform your doctor about the list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use because certain medications may interact with Womab Injection and reduce effectiveness by causing undesirable side effects.
Fact Box
|
Molecule name |
Pertuzumab |
|
Therapeutic class |
Antineoplastics |
|
Pharmacological class |
Monoclonal antibody (mAb) |
|
Indications |
Treatment of HER2-positive breast cancer |
References
-
Roche Products Ltd, Electronic medicines compendium (emc), [Revised on January 2022] [ Accessed on 15 March 2023], https://www.medicines.org.uk/emc/files/pil.2993.pdf
-
Komal Jhaveri, Francisco J Esteva; Pertuzumab in the treatment of HER2+ breast cancer; Journal of the National Comprehensive Cancer Network; Published on April 2014; Accessed on 15 March 2023; https://pubmed.ncbi.nlm.nih.gov/24717573/
- Kei Ishii; Pertuzumab in the treatment of HER2-positive breast cancer: An evidence-based review of its safety, efficacy, and place in therapy; [Published online on 31st Oct 2019];[Accessed on 21st Feb 2023]; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827570
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vikas B S
Pharm D

Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)

Want to know more?
Read Our Editorial Policy







